← Eichor
Condition: Bone Sarcoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Bone Sarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
Phase 1 · 1 location(s) · Emory University · NCT06492954Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumo
Phase 1/Phase 2 · 71 location(s) · Merck Sharp & Dohme LLC · NCT06395103Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT06749366Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
Phase N/A · 3 location(s) · Mayo Clinic · NCT05033288Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Phase 1 · 1 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT06235125A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · 202 location(s) · National Cancer Institute (NCI) · NCT05691478Single Arm Romiplostim to Prevent CIT
EARLY_Phase 1 · 2 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07048249Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07066982Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05051059Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas
Phase N/A · 2 location(s) · Leiden University Medical Center · NCT04832620Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory
Phase 1 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03721068Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas
Phase N/A · 1 location(s) · Istituto Ortopedico Rizzoli · NCT07685405Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT07215611Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Phase 2 · 1 location(s) · CNBG-Virogin Biotech (Shanghai) Ltd. · NCT06126510At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
Phase 1/Phase 2 · 1 location(s) · Peking University People's Hospital · NCT07479732Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma
Phase 1 · 1 location(s) · Sun Yat-sen University · NCT07648069Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
Phase 1 · 1 location(s) · Stanford University · NCT06500819Observational Study in Localized Osteosarcoma
Phase N/A · 16 location(s) · Italian Sarcoma Group · NCT04890067An Observational Study of Local Relapse After High Grade Osteosarcoma
Phase N/A · 2 location(s) · Istituto Ortopedico Rizzoli · NCT06017518Pediatric PET/MR Image Registry
Phase N/A · 1 location(s) · Stanford University · NCT03458520A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05926492KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)
Phase 1 · 1 location(s) · TCRx Therapeutics Co.Ltd · NCT07596693A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Phase 2 · 6 location(s) · Nationwide Children's Hospital · NCT05135975PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Phase 2 · 1 location(s) · Ruijin Hospital · NCT06074692A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
Phase 2 · 1 location(s) · Beijing Konruns Pharmaceutical Co., Ltd. · NCT06564272A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intr
Phase 2 · 1 location(s) · Vall d'Hebron Institute of Oncology · NCT06650514Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diag
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT07428993Musculoskeletal Cancers Remote Monitoring and Care
NA · 1 location(s) · Case Comprehensive Cancer Center · NCT07129226Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
Phase 1 · 3 location(s) · Peking University People's Hospital · NCT06340204
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.